Neuroendostrine Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-08-13
Clinical Trial Update: A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 [Phase 2]
Phase 2 trial evaluating cabozantinib in adults with advanced, low-proliferative neuroendocrine neoplasms (NET G3), including neuroendocrine…